Terms: = Lymphoma AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Treatment
1926 results:
1. Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R-CHOP chemotherapy.
Kwak K; Park Y; Kim BS; Kang KW
Sci Rep; 2024 May; 14(1):11229. PubMed ID: 38755279
[TBL] [Abstract] [Full Text] [Related]
2. Primary colon lymphomas: An analysis of our experience over the last 18 years.
Hasturk D; Akturk Esen S; Buyukaksoy M; Civelek B; Seven I; Uncu D
Medicine (Baltimore); 2024 May; 103(19):e38013. PubMed ID: 38728507
[TBL] [Abstract] [Full Text] [Related]
3. [Effect of L-Type Amino Acid Transporter 1 Expression on Clinicopathological Features and Prognosis of Non-Hodgkin's lymphoma].
Zhao ZF; Hao XJ; Yang YM; Xu WG; Zhang YX; Yuan XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):434-438. PubMed ID: 38660848
[TBL] [Abstract] [Full Text] [Related]
4. Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan.
Edahiro Y; Ochiai T; Hashimoto Y; Ichii M; Okatani T; Omura H; Nakajima K; Sasaki M; Ando J; Takaku T; Koike M; Izumiyama K; Hiraga J; Yano T; Usuki K; Ohtsuka E; Yokoyama K; Oyake T; Takahashi N; Nishida T; Nakao T; Fukuda Y; Akasaka T; Mugitani A; Ando M; Komatsu N
Hematology; 2024 Dec; 29(1):2340149. PubMed ID: 38626148
[TBL] [Abstract] [Full Text] [Related]
5. Low-molecular-weight fucoidan increases telomere length and immunostimulatory effects on NK-92 cells following inhaled anesthetic injury.
Chang CH; Hwang PA
Mutat Res; 2024; 828():111857. PubMed ID: 38603928
[TBL] [Abstract] [Full Text] [Related]
6. High yield killing of lymphoma cells by anti-CD22 CAR-NK cell therapy.
Abbaszade Dibavar M; Soleimani M; Mohammadi MH; Zomorrod MS
In Vitro Cell Dev Biol Anim; 2024 Apr; 60(4):321-332. PubMed ID: 38589736
[TBL] [Abstract] [Full Text] [Related]
7. Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing.
Jeon MJ; Yu ES; Kim DS; Choi CW; Kim HN; Kwon JA; Yoon SY; Yoon J
J Clin Lab Anal; 2024 Mar; 38(6):e25027. PubMed ID: 38506403
[TBL] [Abstract] [Full Text] [Related]
8. Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC.
Melchior L; Hirschmann A; Hofman P; Bontoux C; Concha A; Mrabet-Dahbi S; Vannuffel P; Watkin E; Putzová M; Scarpino S; Cayre A; Martin P; Stoehr R; Hartmann A
Virchows Arch; 2024 Apr; 484(4):677-686. PubMed ID: 38492039
[TBL] [Abstract] [Full Text] [Related]
9. Influence of Minimal Residual Disease at Day 15 of Induction Therapy on Survival of Children with Acute Lymphoblastic Leukemia.
Samardžić-Predojević J; Đurđević-Banjac B; Malčić-Zanić D
Acta Med Acad; 2023 Dec; 52(3):153-160. PubMed ID: 38407081
[TBL] [Abstract] [Full Text] [Related]
10. Economic Evaluation of Targeted Therapies for Anaplastic lymphoma Kinase- and ROS1 Fusion-Positive Non-Small Cell Lung Cancer in India.
Gupta D; Gupta N; Singh N; Prinja S
JCO Glob Oncol; 2024 Feb; 10():e2300260. PubMed ID: 38359374
[TBL] [Abstract] [Full Text] [Related]
11. Gemcitabine-based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: No difference in outcomes.
Liu H; Zou H; Shan D; Liu W; Huang W; Sui W; Deng S; Wang T; Lv R; Fu M; Xu Y; Yi S; An G; Zhao Y; Qiu L; Zou D
Cancer Med; 2024 Jan; 13(2):e6965. PubMed ID: 38348996
[TBL] [Abstract] [Full Text] [Related]
12. Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia.
Jabbour E; Zugmaier G; Agrawal V; Martínez-Sánchez P; Rifón Roca JJ; Cassaday RD; Böll B; Rijneveld A; Abdul-Hay M; Huguet F; Cluzeau T; Díaz MT; Vucinic V; González-Campos J; Rambaldi A; Schwartz S; Berthon C; Hernández-Rivas JM; Gordon PR; Brüggemann M; Hamidi A; Chen Y; Wong HL; Panwar B; Katlinskaya Y; Markovic A; Kantarjian H
Am J Hematol; 2024 Apr; 99(4):586-595. PubMed ID: 38317420
[TBL] [Abstract] [Full Text] [Related]
13. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
14. Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphoma.
Nie EH; Su YJ; Baird JH; Agarwal N; Bharadwaj S; Weng WK; Smith M; Dahiya S; Han MH; Dunn JE; Kipp LB; Miklos DB; Scott BJ; Frank MJ
Blood Adv; 2024 Mar; 8(6):1474-1486. PubMed ID: 38295285
[TBL] [Abstract] [Full Text] [Related]
15. Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis.
Yang P; Cai M; Cao Y; Fan S; Tang W; Ji M; Huang L; Wang F; Zhao W; Niu T; Mo X
Br J Haematol; 2024 Apr; 204(4):1414-1421. PubMed ID: 38272453
[TBL] [Abstract] [Full Text] [Related]
16. Hypofractionated Radiotherapy for Hematologic Malignancies during the COVID-19 Pandemic and Beyond.
Antony F; Dubey A; Skrabek P; Tsang LF; Lambert P; Bybel B; Ahmed N
Curr Oncol; 2024 Jan; 31(1):383-393. PubMed ID: 38248110
[TBL] [Abstract] [Full Text] [Related]
17. CXCL13 in Cerebrospinal Fluid: Clinical Value in a Large Cross-Sectional Study.
Erhart DK; Klose V; Schäper T; Tumani H; Senel M
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203597
[TBL] [Abstract] [Full Text] [Related]
18. Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.
Dreyling M; Fowler NH; Dickinson M; Martinez-Lopez J; Kolstad A; Butler J; Ghosh M; Popplewell L; Chavez JC; Bachy E; Kato K; Harigae H; Kersten MJ; Andreadis C; Riedell PA; Ho PJ; Pérez-Simón JA; Chen AI; Nastoupil LJ; von Tresckow B; María Ferreri AJ; Teshima T; Patten PEM; McGuirk JP; Petzer AL; Offner F; Viardot A; Zinzani PL; Malladi R; Paule I; Zia A; Awasthi R; Han X; Germano D; O'Donovan D; Ramos R; Maier HJ; Masood A; Thieblemont C; Schuster SJ
Blood; 2024 Apr; 143(17):1713-1725. PubMed ID: 38194692
[TBL] [Abstract] [Full Text] [Related]
19. Artificial intelligence performance in detecting lymphoma from medical imaging: a systematic review and meta-analysis.
Bai A; Si M; Xue P; Qu Y; Jiang Y
BMC Med Inform Decis Mak; 2024 Jan; 24(1):13. PubMed ID: 38191361
[TBL] [Abstract] [Full Text] [Related]
20. Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell lymphoma: Data from the First-in-Human Phase I Study.
Song Y; Jin Z; Li ZM; Liu Y; Li L; He C; Su H; Zhou H; Li K; Hao S; Zuo X; Wu J; Li D; Wu M; Sun X; Qi J; Cai Z; Li Z; Li Y; Huang Y; Shen J; Xiao Z; Zhu J
Clin Cancer Res; 2024 Apr; 30(7):1248-1255. PubMed ID: 38190117
[TBL] [Abstract] [Full Text] [Related]
[Next]
